Sabine Royalty Trust declared a cash distribution of $0.286230 per unit for March 2026, payable on March 30, 2026. The distribution reflects December 2025 oil production of 49,137 barrels at $54.40/barrel and November 2025 gas production of 931,107 Mcf at $2.73/Mcf. This month's distribution increased due to higher oil production and natural gas pricing, despite lower oil prices and decreased gas production.

Sabine Royalty Trust (NYSE: SBR) declared a cash distribution of $0.283370 per unit for February 2026, payable on February 27, 2026. The distribution decreased from the previous month due to lower oil and natural gas production volumes and reduced commodity prices. Preliminary production volumes were approximately 45,316 barrels of oil and 1,026,714 Mcf of gas at prices of $59.01 per barrel and $2.27 per Mcf, respectively.

Sabine Royalty Trust declared a monthly cash distribution of $0.321550 per unit for January 2026, payable on January 29, 2026. The distribution reflects October 2025 oil production of approximately 56,504 barrels at $61.05/barrel and September 2025 gas production of 1,314,850 Mcf at $2.31/Mcf. While production volumes increased, the distribution was partially offset by lower commodity prices and higher Ad Valorem taxes ($804,000 vs. $259,000 year-over-year).

The article discusses three high-risk, high-yield royalty trusts in the oil and gas sector: Sabine Royalty Trust, Cross Timbers Royalty Trust, and PermRock Royalty Trust. These trusts offer high dividend yields but are volatile due to their dependence on oil and gas prices.

The article explores four monthly dividend stocks across different sectors like royalty trusts, business development companies, and mortgage REITs, highlighting their unique characteristics, yields ranging from 8% to 19.8%, and potential investment considerations.

Shares of Applied Therapeutics, Inc. (NASDAQ: APLT) shares fell sharply during Friday’s session after the company released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of progression to overt heart failure. The study's primary endpoint was stabilization or improvement in cardiac functional capacity as measured by Peak VO2 in patients treated with AT-001 1500mg twice daily (BID) compared to placebo. Applied Therapeutics shares dipped 35.6% to $2.4498 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Ainos, Inc.(NASDAQ: AIMD) jumped 112.6% to $3.6805 after falling more than 12% on Thursday. Revelstone Capital Acquisition Corp. (NASDAQ: RCAC) shares climbed 89.6% to $10.71. Revelstone Capital Acquisition cancelled special meeting to approve business combination with Set Jet, Inc. Banzai International, Inc. (NASDAQ: BNZI) surged 74% to $2.92. Banzai International signed a non-binding letter of intent to acquire IGLeads, a cutting-edge automated lead generation platform. Safe and Green Development Corporation (NASDAQ: SGD) shares rose 56.5% to $2.1307. Safe And Green Development recently issued an update on LOI for acquisition of Xene AI Software platform. NexImmune, Inc. (NASDAQ: NEXI) gained 30% to $7.67 Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose climbed 27.8% to $0.78 after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Polished.com Inc. (NYSE: POL) gained 27.2% to $8.05. Swvl Holdings Corp. (NASDAQ: SWVL) gained 27.2% to $2.90. PolyPid Ltd. (NASDAQ: PYPD) gained 25% to $8.44. PolyPid announced $16.2 million private placement of 3,371,312 shares at $4.81 per share. AxoGen, Inc. (NASDAQ: AXGN) jumped 20.4% to $8.13 as the company reported ...

Not all dividend checks are sent four times a year. A handful of companies actually offer a smaller payout every month instead.

Smart Beta ETF report for DIV

Smart Beta ETF report for DIV

Smart Beta ETF report for DIV

Smart Beta ETF report for DIV

Smart Beta ETF report for DIV